Understanding Opioid Addiction
Opioid addiction is a chronic disorder characterized by compulsive drug seeking and use, despite harmful consequences. It affects millions globally, contributing to significant morbidity, mortality, and economic burden. Driven by the overuse of prescription pain relievers, heroin, and synthetic opioids like fentanyl, the opioid crisis remains a pressing public health challenge.
At MuriPhys, we provide specialized preclinical research solutions to help develop therapies aimed at treating opioid dependence, mitigating withdrawal symptoms, and preventing relapse.
Precision Drug Delivery for Addiction Models
Developing effective treatments for opioid addiction requires precise targeting of neural circuits involved in reward, dependence, and withdrawal. MuriPhys offers advanced delivery methods to optimize therapeutic administration in preclinical models:
- Intracerebroventricular (ICV) Injection – Targets central brain regions involved in addiction pathways.
- Intraperitoneal (IP) Injection – Facilitates systemic delivery of therapeutics to modulate opioid receptors.
- SC and IV Administration: Routes with different absorption and exposure characteristics, selected for the study and formulation.
- Oral Gavage (OG) – Mimics human oral drug intake for long-term therapeutic studies.
These delivery methods enable comprehensive exploration of pharmacological agents that can counteract opioid addiction and enhance recovery.
Behavioral Assays – Modeling Addiction and Relapse
Behavioral assays are essential for understanding the complexities of opioid addiction, from craving and withdrawal to relapse. MuriPhys offers a robust suite of behavioral models that replicate critical aspects of addiction:
- Conditioned Place Preference (CPP) – Measures the reinforcing effects of opioids and the efficacy of potential treatments in blocking drug-seeking behavior.
- Self-Administration Models – Evaluate voluntary opioid intake and assess drug-seeking tendencies.
- Withdrawal Assays: Characterize protocol-defined behavioral or physiological features of withdrawal in the selected model.
- Open Field Test – Assesses anxiety, locomotion, and exploratory behavior during withdrawal or relapse phases.
- Shuttle Box Testing – Analyzes decision-making and avoidance behaviors influenced by opioid exposure.
These assays facilitate the identification of compounds that reduce opioid cravings and prevent relapse, contributing to the development of long-term solutions.
Electrophysiology – Unlocking Neural Pathways of Addiction
Opioid addiction disrupts neural circuits involved in reward and impulse control. MuriPhys utilizes EEG and EMG technologies to map these disruptions and evaluate how therapeutic interventions restore normal neural function:
- EEG Monitoring – Tracks changes in brain activity associated with craving, withdrawal, and relapse.
- EMG Analysis – Measures muscle responses, reflecting physiological changes during opioid withdrawal.
Electrophysiological data provide crucial insights into addiction neurobiology, informing the development of targeted interventions that normalize brain activity.
Imaging and Biomarker Analysis
Monitoring the physiological effects of opioids and assessing treatment responses are vital for addiction research. MuriPhys employs advanced imaging and partners with third party CROs for biomarker analyses to enhance preclinical studies:
- In Vivo Imaging – Tracks neural and physiological responses to opioid exposure and therapeutic interventions.
- Biochemical Analysis – Measures neurotransmitter levels, stress hormones, and inflammatory markers associated with addiction.
- Histopathology – Examines structural changes in brain regions implicated in addiction.
These tools provide comprehensive insights into the biological underpinnings of opioid addiction and the efficacy of emerging treatments.
Why Choose MuriPhys for Opioid Addiction Research?
MuriPhys connects delivery, behavioral assays, electrophysiology and imaging for preclinical opioid-use research. The model, controls, method readiness and interpretation are agreed for the study.
Contact us to learn how MuriPhys can support your opioid addiction research initiatives.